×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中南大学 [7]
南华大学 [3]
中国医学科学院 北京... [1]
内容类型
期刊论文 [11]
发表日期
2019 [3]
2017 [1]
2016 [3]
2014 [1]
2013 [2]
2011 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD-AF Registry
期刊论文
2019, 卷号: 8, 期号: 3
作者:
Goto, Shinya
;
Angchaisuksiri, Pantep
;
Bassand, Jean-Pierre
;
Camm, A. John
;
Dominguez, Helena
收藏
  |  
浏览/下载:107/0
  |  
提交时间:2020/01/03
atrial fibrillation
chronic kidney disease
GARFIELD-AF registry
outcomes research
registry
betablockers inhibit the viability of breast cancer cells by regulating the ERK/COX2 signaling pathway and the drug response is affected by ADRB2 singlenucleotide polymorphisms.
期刊论文
Oncology Reports, 2019, 卷号: 41, 期号: 1, 页码: 341-350
作者:
Xie, Wan-Ying
;
He, Ruo-Hui
;
Zhang, Jun
;
He, Yi-Jing
;
Wan, Zan
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/27
Mitogen-activated protein kinase signaling pathway
Triple-negative breast cancer
β 2 -adrenergic receptor single-nucleotide polymorphisms
β-adrenergic receptor
β-blocker
-blockers inhibit the viability of breast cancer cells by regulating the ERK/COX-2 signaling pathway and the drug response is affected by ADRB2 single-nucleotide polymorphisms
期刊论文
ONCOLOGY REPORTS, 2019, 卷号: 41, 期号: 1, 页码: 341-350
作者:
Xie, Wan-Ying
;
He, Ruo-Hui
;
Zhang, Jun
;
He, Yi-Jing
;
Wan, Zan
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/27
triple-negative breast cancer
-blocker
-adrenergic receptor
mitogen-activated protein kinase signaling pathway
(2)-adrenergic receptor single-nucleotide polymorphisms
miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer
期刊论文
BMC Cancer, 2017, 卷号: 17, 期号: 1, 页码: 886
作者:
Huang, Jin
;
He, Yijing
;
Mcleod, Howard L
;
Xie, Yanchun
;
Xiao, Desheng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/03
*EphA2
*Epithelial-mesenchymal transition
*Gastric cancer
*Wnt/beta-catenin
*miR-302b
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
期刊论文
Oncotarget, 2016, 卷号: 7, 期号: 42, 页码: 68314-68327
作者:
Zhou, Chengfang
;
Chen, Xiang
;
Zeng, Weiqi
;
Peng, Cong
;
Huang, Gang
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/03
melanoma
propranolol
apoptosis
AKT pathway
MAPK pathway
The pharmacogenomics of drug resistance to protein kinase inhibitors
期刊论文
Drug Resistance Updates, 2016, 卷号: 28, 页码: 28-42
作者:
Gillis, Nancy K.
;
McLeod, Howard L.*
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/03
Pharmacogenetics
Pharmacogenomics
Cancer
Resistance
Somatic mutations
The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference
期刊论文
Pharmacogenomics, 2016, 卷号: 17, 期号: 1, 页码: 59-74
作者:
He, Ruo-Hui
;
He, Yi-Jing
;
Tang, Yong-Jun
;
Zhou, Hong-Hao
;
McLeod, Howard L
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/27
cancer progression
polymorphisms
tumor biology behaviors
beta-adrenergic receptors
beta-blockers
Epigenetic perspectives on cancer chemotherapy response
期刊论文
Pharmacogenomics, 2014, 卷号: 15, 期号: 5, 页码: 699-715
作者:
Liu, Mou-Ze
;
McLeod, Howard L.
;
He, Fa-Zhong
;
Chen, Xiao-Ping
;
Zhou, Hong-Hao
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/03
ADME
anticancer drug
biomarker
chemotherapy
DNA methylation
epidrug
epigenetic
histone modification
individualized medicine
miRNA
Gastric cancer pharmacogenetics: progress or old tripe?
期刊论文
Pharmacogenomics, 2013, 卷号: 14, 期号: 9, 页码: 1053-1064
作者:
Patel, Jai N.
;
Fuchs, Charles S.
;
Owzar, Kouros
;
Chen, Zihua
;
McLeod, Howard L.*
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/03
Association
Cancer
Gastric
Genetic
Germline
Mutation
Pharmacogenetics
Variation
Current pharmacogenomic studies on hERG potassium channels
期刊论文
Trends in Molecular Medicine, 2013, 卷号: 19, 期号: 4, 页码: 227-238
作者:
He, Fa-Zhong
;
McLeod, Howard L.
;
Zhang, Wei*
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/03
hERG potassium channels
pharmacogenomics
polymorphism
safety assessment
adverse drug reaction
personalized therapy
©版权所有 ©2017 CSpace - Powered by
CSpace